Funding · Company
Ratio Therapeutics, Inc.
Boston, MABiotech & Pharma
Ratio Therapeutics, Inc. of Boston, MA has disclosed $121M across 2 Form D offerings filed with the SEC between Dec 21, 2023 and Jul 31, 2026.
$121M
Total disclosed
2
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2021SEC CIK0002004792Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →